Climb Bio, Inc.

This study is testing an experimental antibody called budoprutug in adults with primary membranous nephropathy, a rare autoimmune kidney disease. Researchers want to see if the treatment is safe and can help reduce kidney damage by targeting specific immune cells. About 45 partic…

This is an early safety study of an experimental drug called budoprutug for adults with active systemic lupus erythematosus (SLE). The main goal is to see if different single doses are safe and well-tolerated in about 30 participants whose lupus hasn't responded well to standard …

This early-stage study is testing a new antibody drug called budoprutug in adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The main goal is to check if the drug is safe and well-tolerated, while also seeing if it helps raise plate…

This is the first study testing CLYM116 in people. Researchers want to see if this experimental antibody is safe and how it behaves in the body. The study will enroll 48 healthy adults who will receive either the drug or a placebo. The main goal is to check for side effects and m…